These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14679266)

  • 1. Results of clinical trials sponsored by for-profit vs nonprofit entities.
    Palmer RH
    JAMA; 2003 Dec; 290(23):3070; author reply 3071-2. PubMed ID: 14679266
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of clinical trials sponsored by for-profit vs nonprofit entities.
    Rosefsky JB
    JAMA; 2003 Dec; 290(23):3070-1; author reply 3071-2. PubMed ID: 14679267
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of clinical trials sponsored by for-profit vs nonprofit entities.
    Waldorff S
    JAMA; 2003 Dec; 290(23):3071; author reply 3071-2. PubMed ID: 14679268
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
    JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].
    Als-Nielsen BE; Chen W; Gluud CN; Gluud LL
    Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406
    [No Abstract]   [Full Text] [Related]  

  • 7. Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions.
    Jørgensen AW; Maric KL; Tendal B; Faurschou A; Gøtzsche PC
    BMC Med Res Methodol; 2008 Sep; 8():60. PubMed ID: 18782430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry sponsored bias: NICE may be biased too.
    Toal MJ
    BMJ; 2011 Jan; 342():d474. PubMed ID: 21266434
    [No Abstract]   [Full Text] [Related]  

  • 10. The uncertainty principle and industry-sponsored research.
    Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
    Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
    Ridker PM; Torres J
    JAMA; 2006 May; 295(19):2270-4. PubMed ID: 16705108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature.
    Khan SN; Mermer MJ; Myers E; Sandhu HS
    Am J Orthop (Belle Mead NJ); 2008 Dec; 37(12):E205-12; discussion E212. PubMed ID: 19212579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Clinical Trials Directive: the Italian position.
    Filibeck U; Addis A; Tomino C; Martini N
    Lancet; 2004 May; 363(9421):1651-2. PubMed ID: 15145650
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical intervention research: two editorials and one discussion].
    Jensen GB; Ersbøll J
    Ugeskr Laeger; 2005 May; 167(21):2307-8; author reply 2308-10. PubMed ID: 15962866
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 19. Sponsorship, authorship, and accountability.
    Landow L
    N Engl J Med; 2002 Jan; 346(4):290-2. PubMed ID: 11807158
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.